Get 30% off on all global market reports with code ONLINE30 – stay updated on tariff changes, macroeconomic trends, and more!
Clinical Trial Imaging Industry Expansion: How the Market Size Has Grown Over the Last 5 Years?
The sector for clinical trial imaging has seen a robust growth in its market size in recent times. The segment is set to witness an escalation from $1.44 billion in 2024, to a staggering $1.58 billion by 2025. The compound annual growth rate (CAGR) of this upswing is projected at 9.3%. This remarkable progress during the historical span can be credited to factors such as amplified sales and dissemination of clinical imaging software and services, heightening risks concerning breast cancer, proliferation in healthcare spending, an upward trend in healthcare outlay leading to enhanced infrastructure, plus a spurred increase in research and development investment by pharmaceutical and biotechnological enterprises.
Strong expansion is anticipated in the clinical trial imaging market over the coming years. With an estimated compound annual growth rate (CAGR) of 8.7%, it is predicted to reach $2.2 billion by 2029. This growth can be credited to various factors including intensifying chronic disease rates, escalating research and development costs, growing numbers of the elderly population, increased clinical trials, and the surge of contract research organizations. Key trends expected during this forecast period revolve around technological progress improving imaging modes, strategic moves from market players to enhance abilities and services, the incorporation of imaging-centric approaches in drug evolution, advancement in molecular imaging and AI-powered analysis, and product innovation.
Claim Your Free Sample Report:
http://www.thebusinessresearchcompany.com/sample….p;type=smp
What Growth Drivers Are Responsible for Accelerating Clinical Trial Imaging Market Growth?
The growth of the clinical trial imaging market is anticipated to accelerate, driven by the rising occurrence of chronic illnesses. These long-lasting diseases often necessitate continuous medical intervention and may impede regular activities or the quality of life.
The surge in chronic diseases can be attributed to factors such as exposure to air pollution, chemicals, toxins, changes in lifestyle, and genetics. Clinical trial imaging offers efficient monitoring that can aid patients in grasping their conditions and the effects of their treatments, thereby enhancing compliance and satisfaction. For instance, the US-based National Center for Biotechnology Information (NCBI), a division of the National Library of Medicine, projected in January 2023 that by 2050, there would be a 99.5% increase in individuals aged 50 years and above suffering from at least one chronic illness. The number is expected to ascend from 71.522 million in 2020 to 142.66 million. Hence, the escalating incidence of chronic diseases is fuelling the clinical trial imaging market.
Performance of Leading Segments in the Clinical Trial Imaging Global Market
The clinical trial imagingmarket covered in this report is segmented –
1) By Product And Services: Services; Software
2) By Modality: Computed Tomography; Magnetic Resonance Imaging; Echocardiography; Nuclear Medicine; Positron Emission Tomography; X-Ray; Ultrasound; Optical Coherence Tomography; Other Modalities
3) By Application: Oncology; Neurology; Cardiology; Endocrinology; Dermatology; Hematology; Other Applications
4) By Distributer: Direct Sales; Tender Sales
5) By End User: Contract Research Organizations; Pharmaceutical And Biotechnology Companies; Medical Device Manufacturers; Academic And Government Research Institutes; Other End-Users
Subsegments:
1) By Services: Imaging Services For Diagnostics; Image Acquisition Services; Image Analysis Services; Image Management And Archiving Services
2) By Software: Imaging Software For Analysis; Image Processing Software; Radiology Information Systems (RIS); Picture Archiving And Communication Systems (PACS)
Access the Full Report Today:
http://www.thebusinessresearchcompany.com/report/…ket-report
What are the upcoming Trends Poised to Transform the Future of the Clinical Trial Imaging Market?
Leading companies in the clinical trial imaging market are pioneering the development of cloud-based image tools, aimed at enhancing efficiency and effectiveness of clinical trials. These revolutionary tools are software applications and platforms that harness the capacity of cloud technology to store, manage, and scrutinize medical images. As an example, Clarion, an American producer of advanced power distribution systems, launched an innovative cloud-based image viewer tool in March 2023. This state-of-the-art tool provides real-time, accessible, on-demand viewing and manipulation of high-resolution images. It facilitates a nearly real-time read-quality access to images and reduces the need for manual steps that were once necessary, greatly simplifying the image viewing process. It ensures easy accessibility of images while keeping it safe and adhering to data privacy regulations. It also empowers users with full-resolution viewing and manipulation, enabling them to derive significant insights from their trial subjects.
What Are the Regional Hotspots for Clinical Trial Imaging Market Growth?
North America was the largest region in the clinical trial imaging market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical trial imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get a Customized Version of the Report:
http://www.thebusinessresearchcompany.com/customi…p;type=smp
Which Companies Hold the Largest Market Share in the Clinical Trial Imaging Industry?
Major companies operating in the clinical trial imaging market are Koninklijke Philips N.V., Labcorp Drug Development, Icon Plc, PPD Inc., Syneos Health, Charles River Laboratories, Parexel International Corporation, Clario, Medpace Inc., Medidata Solution Inc., Biotelemetry Inc., WIRB-Copernicus Group, ProScan Imaging LLC, Invicro LLC, Perspectum, Radiant Sage LLC, Worldcare Clinical LLC, Intrinsic Imaging LLC, Datatrak Inc., IXICO Plc, Calyx Inc., Resonance Health Ltd., Anagram-ESIC SL
Access the Complete Report:
http://www.thebusinessresearchcompany.com/purchas…x?id=15765
How Our Market Research Reports Help Maximize ROI Across Industries:
* Identify High-Growth Opportunities: Pinpoint emerging trends, untapped segments, and regional hotspots that align with your strategic goals.
* Reduce Investment Risk: Make data-driven decisions with confidence by understanding market dynamics, key drivers, and competitive threats.
* Optimize Strategic Planning: Align your product development, marketing, and expansion plans with industry forecasts and customer behaviour insights.
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
News From
The Business Research Company …
Category: Industry Reports & Market Analysis Profile: The Business Research Company is a leading market research and consulting services provider. It offers over 9,500 market reports across 27 industries in 60+ geographies, providing detailed insights and forecasts. Its customised research solutions support companies in making critical decisions, while its continuous research service enhances organizational capabilities. The flagship Global Market Model database provides comprehensive market intelligence with 1,500,000 datasets covering 8,000+ mark …
This email address is being protected from spambots. You need JavaScript enabled to view it.
